Activin A Suppresses Osteoblast Mineralization Capacity by Altering Extracellular Matrix (ECM) Composition and Impairing Matrix Vesicle (MV) Production*

During bone formation, osteoblasts deposit an extracellular matrix (ECM) that is mineralized via a process involving production and secretion of highly specialized matrix vesicles (MVs). Activin A, a transforming growth factor-β (TGF-β) superfamily member, was previously shown to have inhibitory effects in human bone formation models through unclear mechanisms. We investigated these mechanisms elicited by activin A during in vitro osteogenic differentiation of human mesenchymal stem cells (hMSC). Activin A inhibition of ECM mineralization coincided with a strong decline in alkaline phosphatase (ALP1) activity in extracellular compartments, ECM and matrix vesicles. SILAC-based quantitative proteomics disclosed intricate protein composition alterations in the activin A ECM, including changed expression of collagen XII, osteonectin and several cytoskeleton-binding proteins. Moreover, in activin A osteoblasts matrix vesicle production was deficient containing very low expression of annexin proteins. ECM enhanced human mesenchymal stem cell osteogenic development and mineralization. This osteogenic enhancement was significantly decreased when human mesenchymal stem cells were cultured on ECM produced under activin A treatment. These findings demonstrate that activin A targets the ECM maturation phase of osteoblast differentiation resulting ultimately in the inhibition of mineralization. ECM proteins modulated by activin A are not only determinant for bone mineralization but also possess osteoinductive properties that are relevant for bone tissue regeneration.

[1]  H. Anderson.  VESICLES ASSOCIATED WITH CALCIFICATION IN THE MATRIX OF EPIPHYSEAL CARTILAGE , 1969, The Journal of cell biology.

[2]  H. Anderson,et al.  Isolation and characterization of calcifying matrix vesicles from epiphyseal cartilage. , 1970, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. W. Bernard.  Ultrastructural observations of initial calcification in dentine and enamel. , 1972, Journal of ultrastructure research.

[4]  H. Anderson,et al.  Pyrophosphate stimulation of calcium uptake into cultured embryonic bones. Fine structure of matrix vesicles and their role in calcification. , 1973, Developmental biology.

[5]  H. O. Sweet,et al.  Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. , 1976, The American journal of pathology.

[6]  D. Heinegård,et al.  Cartilage proteoglycan aggregate formation. Role of link protein. , 1981, The Biochemical journal.

[7]  R Guillemin,et al.  Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Joan Vaughan,et al.  Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid , 1986, Nature.

[9]  A. Mason,et al.  Selective and indirect modulation of human multipotential and erythroid hematopoietic progenitor cell proliferation by recombinant human activin and inhibin. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Canalis,et al.  Growth factors and the regulation of bone remodeling. , 1988, The Journal of clinical investigation.

[11]  L. N. Wu,et al.  Identification of phospholipid-dependent calcium-binding proteins as constituents of matrix vesicles. , 1989, The Journal of biological chemistry.

[12]  E. Canalis,et al.  Activin-A binding and biochemical effects in osteoblast-enriched cultures from fetal-rat parietal bone , 1991, Molecular and cellular biology.

[13]  K. Takaoka,et al.  Immunolocalization of alkaline phosphatase in osteoblasts and matrix vesicles of human fetal bone. , 1992, Bone and mineral.

[14]  M. Muramatsu,et al.  Induction of differentiation of the human promyelocytic cell line HL-60 by activin/EDF. , 1992, Biochemical and biophysical research communications.

[15]  K. L. Miller,et al.  Bovine bone activin enhances bone morphogenetic protein-induced ectopic bone formation. , 1992, The Journal of biological chemistry.

[16]  D E Ingber,et al.  Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. , 1994, Biophysical journal.

[17]  S. Manolagas.  Bone marrow, cytokines, and bone remodeling , 1995 .

[18]  H. Anderson.  Molecular biology of matrix vesicles. , 1995, Clinical orthopaedics and related research.

[19]  Oldberg,et al.  Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.

[20]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[21]  A. Shevchenko,et al.  Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry , 1996, Nature.

[22]  C. Damsky,et al.  Interactions between integrin receptors and fibronectin are required for calvarial osteoblast differentiation in vitro. , 1997, Journal of cell science.

[23]  W. Vale,et al.  Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation , 1997, Molecular and cellular biology.

[24]  R. Derynck,et al.  Osteoblastic responses to TGF-beta during bone remodeling. , 1998, Molecular biology of the cell.

[25]  R. Derynck,et al.  Osteoblastic Responses to TGF-β during Bone Remodeling , 1998 .

[26]  E. Sage,et al.  Regulation of SPARC expression during early Xenopus development: Evolutionary divergence and conservation of DNA regulatory elements between amphibians and mammals , 1998, Development Genes and Evolution.

[27]  P. Fratzl,et al.  Matrix mineralization in MC3T3-E1 cell cultures initiated by beta-glycerophosphate pulse. , 1998, Bone.

[28]  Y. Iwamoto,et al.  Inhibitory effects of activin‐a on osteoblast differentiation during cultures of fetal rat calvarial cells , 1999, Journal of cellular biochemistry.

[29]  J. Baum,et al.  Folding of peptide models of collagen and misfolding in disease. , 1999, Current opinion in structural biology.

[30]  Y. Takeuchi,et al.  The Primary Calcification in Bones Follows Removal of Decorin and Fusion of Collagen Fibrils , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  Ying Chen,et al.  Matrix Vesicle Plasma Cell Membrane Glycoprotein‐1 Regulates Mineralization by Murine Osteoblastic MC3T3 Cells , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  H. Nah,et al.  The Roles of Annexins and Types II and X Collagen in Matrix Vesicle-mediated Mineralization of Growth Plate Cartilage* , 2000, The Journal of Biological Chemistry.

[33]  S. Fujita,et al.  Activin increases bone mass and mechanical strength of lumbar vertebrae in aged ovariectomized rats. , 2000, Bone.

[34]  M. Amling,et al.  Osteopenia and decreased bone formation in osteonectin-deficient mice , 2000, The Journal of clinical investigation.

[35]  T. Chambers,et al.  Activin A is an essential cofactor for osteoclast induction. , 2000, Biochemical and biophysical research communications.

[36]  G. Risbridger,et al.  Activins and inhibins in endocrine and other tumors. , 2001, Endocrine reviews.

[37]  Y. Wang,et al.  Inverse 15N-metabolic labeling/mass spectrometry for comparative proteomics and rapid identification of protein markers/targets. , 2002, Rapid communications in mass spectrometry : RCM.

[38]  R. Jilka,et al.  Inhibin suppresses and activin stimulates osteoblastogenesis and osteoclastogenesis in murine bone marrow cultures. , 2002, Endocrinology.

[39]  T. Ueda,et al.  Glycolysis and Glutamate Accumulation into Synaptic Vesicles , 2003, The Journal of Biological Chemistry.

[40]  I. Kalajzic,et al.  Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. , 2003, Endocrinology.

[41]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[42]  Douglas A. Hosack,et al.  Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.

[43]  C. Chung,et al.  Fibronectin fragment promotes osteoblast-associated gene expression and biological activity of human osteoblast-like cell , 2003, Biotechnology Letters.

[44]  Henrik Birkedal,et al.  Influence of the degradation of the organic matrix on the microscopic fracture behavior of trabecular bone. , 2004, Bone.

[45]  J. Aubin.  Regulation of Osteoblast Formation and Function , 2004, Reviews in Endocrine and Metabolic Disorders.

[46]  H. Anderson,et al.  The role of matrix vesicles in growth plate development and biomineralization. , 2005, Frontiers in bioscience : a journal and virtual library.

[47]  M. Eijken,et al.  The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization , 2006, Molecular and Cellular Endocrinology.

[48]  A. Boskey,et al.  The inhibitory effect of cartilage proteoglycans on hydroxyapatite growth , 1984, Calcified Tissue International.

[49]  Ye Guang Chen,et al.  Activin Signaling and Its Role in Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis , 2006, Experimental biology and medicine.

[50]  T. Pierson,et al.  Inhibin A is an endocrine stimulator of bone mass and strength. , 2007, Endocrinology.

[51]  K. Nagashima,et al.  Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts , 2007, Journal of cellular physiology.

[52]  F. Ottensmeyer,et al.  Vectorial sequence of mineralization in the turkey leg tendon determined by electron microscopic imaging , 2007, Calcified Tissue International.

[53]  A. Uitterlinden,et al.  The FASEB Journal • Research Communication The activin A-follistatin system: potent regulator of human extracellular matrix mineralization , 2022 .

[54]  A. Boskey,et al.  Mechanisms of proteoglycan inhibition of hydroxyapatite growth , 1985, Calcified Tissue International.

[55]  C. Kielty,et al.  Fibrillin-1 regulates the bioavailability of TGFβ1 , 2007, The Journal of cell biology.

[56]  M. Bouxsein,et al.  A soluble activin Type IIA receptor induces bone formation and improves skeletal integrity , 2008, Proceedings of the National Academy of Sciences.

[57]  N. Chen,et al.  Annexin‐Mediated Matrix Vesicle Calcification in Vascular Smooth Muscle Cells , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[58]  L. Suva,et al.  Regulation of osteoblastogenesis and osteoclastogenesis by the other reproductive hormones, Activin and Inhibin , 2009, Molecular and Cellular Endocrinology.

[59]  T. Veenstra,et al.  Proteomic analysis of extracellular matrix and vesicles. , 2009, Journal of proteomics.

[60]  H. Yoshikawa,et al.  Transient dynamic actin cytoskeletal change stimulates the osteoblastic differentiation , 2009, Journal of Bone and Mineral Metabolism.

[61]  Jürgen Cox,et al.  A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics , 2009, Nature Protocols.

[62]  D. Bigner,et al.  Proteomic and immunologic analyses of brain tumor exosomes , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[63]  R. Baron,et al.  A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys. , 2010, Bone.

[64]  M. Eijken,et al.  1α,25‐(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles , 2010, Journal of cellular physiology.

[65]  H. Karlic,et al.  Extra-cellular matrix suppresses expression of the apoptosis mediator Fas by epigenetic DNA methylation , 2010, Apoptosis.

[66]  G. Karsenty,et al.  Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation , 2010, Journal of Cell Biology.

[67]  G. Karsenty,et al.  Fibrillin-1 and -2 differentially modulate endogenous TGF-β and BMP bioavailability during bone formation , 2010, The Journal of cell biology.

[68]  K. Jepsen,et al.  Type XII collagen regulates osteoblast polarity and communication during bone formation , 2011, The Journal of cell biology.

[69]  M. Eijken,et al.  GPM6B regulates osteoblast function and induction of mineralization by controlling cytoskeleton and matrix vesicle release , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[70]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.